Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 3 23Phase 1/2 10Phase 1 5Phase NA 3Phase 2/3 3Phase EARLY_PHASE1 2Phase 4 2

Status

Completed 17Terminated 5Unknown 4Withdrawn 3Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Leiomyoma 1Carcinoma, Ductal 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Enoxaparin 5Bevacizumab 5Nivolumab 4Carboplatin 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3pembrolizumab 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Letrozole × Clear all
NCT06143631 2026-05-20

PLUM

University of California, San Francisco

Phase 4 Recruiting
140 enrolled

Leiomyoma

NCT05183828 2026-01-26

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

University of Washington

Phase 4 Recruiting
68 enrolled

Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡